NovaScan Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.08M
- Investors
-
13
NovaScan General Information
Description
Developer of a non-invasive virus detection platform designed for cancer detection and stratification. The company has active programs in skin, lung, GI, and breast cancer, and its technology can be used in minimally invasive procedures and can be used to dose therapeutics into live tumors, enabling physicians to improve patient outcomes, increase physician economics, and reduce the cost of care.
Contact Information
Website
www.novascaninc.comCorporate Office
- 400 North Aberdeen
- Suite 900
- Chicago, IL 60642
- United States
Corporate Office
- 400 North Aberdeen
- Suite 900
- Chicago, IL 60642
- United States
NovaScan Timeline
NovaScan Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 18-Aug-2026 | $3.08M | Completed | Generating Revenue | ||
| 13. Secondary Transaction - Private | 01-Jun-2026 | Completed | Generating Revenue | |||
| 12. Grant | 21-Nov-2025 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 29-Nov-2022 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B) | 17-Nov-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 24-Jul-2017 | Completed | Generating Revenue | |||
| 8. Grant | 11-Aug-2016 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 10-Aug-2016 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | $1.78M | Completed | Generating Revenue | |||
| 5. Grant | 04-Jan-2015 | $2.3M | $1.78M | Completed | Generating Revenue |
NovaScan Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NovaScan Patents
NovaScan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260140102-A1 | Impedance measurement using bipolar configurations of electrodes | Pending | 15-Nov-2024 | ||
| WO-2026106923-A1 | Impedance measurement using bipolar configurations of electrodes | Pending | 15-Nov-2024 | ||
| JP-2025539693-A | Techniques for assessing cancer tissue during surgical biopsy | Pending | 14-Oct-2022 | ||
| AU-2023361311-A1 | Techniques for assessing cancerous tissue during surgical biopsies | Active | 14-Oct-2022 | ||
| AU-2023361311-B2 | Techniques for assessing cancerous tissue during surgical biopsies | Active | 14-Oct-2022 | G01N33/4836 |
NovaScan Signals
NovaScan Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cancer Prevention and Research Institute of Texas | Government | |||
| Aerion Capital | Family Office | |||
| Portal Innovations | Venture Capital | Minority | ||
| BioPacific Investors | Angel Group | Minority | ||
| Builders VC | Venture Capital | Minority |
NovaScan FAQs
-
When was NovaScan founded?
NovaScan was founded in 2003.
-
Where is NovaScan headquartered?
NovaScan is headquartered in Chicago, IL.
-
What is the size of NovaScan?
NovaScan has 16 total employees.
-
What industry is NovaScan in?
NovaScan’s primary industry is Diagnostic Equipment.
-
Is NovaScan a private or public company?
NovaScan is a Private company.
-
What is NovaScan’s current revenue?
The current revenue for NovaScan is .
-
How much funding has NovaScan raised over time?
NovaScan has raised $15.9M.
-
Who are NovaScan’s investors?
Cancer Prevention and Research Institute of Texas, Aerion Capital, Portal Innovations, BioPacific Investors, and Builders VC are 5 of 13 investors who have invested in NovaScan.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process